BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guttmann DM, Mitra N, Bekelman J, Metz JM, Plastaras J, Feng W, Swisher-McClure S. Improved Overall Survival with Aggressive Primary Tumor Radiotherapy for Patients with Metastatic Esophageal Cancer. J Thorac Oncol 2017;12:1131-42. [PMID: 28461255 DOI: 10.1016/j.jtho.2017.03.026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang R, Jia M, Li P, Han J, Huang K, Li Q, Qiao Y, Xu T, Ruan P, Hu Q, Fan G, Song Q, Fu Z. Radiotherapy improves the survival of patients with metastatic esophageal squamous cell carcinoma: a propensity score matched analysis of Surveillance, Epidemiology, and End Results database. Diseases of the Esophagus 2018;32. [DOI: 10.1093/dote/doy074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
2 Zhang R, Zou J, Li P, Li Q, Qiao Y, Han J, Huang K, Ruan P, Lin H, Song Q, Fu Z. Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort. Diseases of the Esophagus 2019. [DOI: 10.1093/dote/doz051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Seyedin SN, Parekh KR, Ginader T, Caster JM. The Role of Definitive Radiation and Surgery in Metastatic Esophageal Cancer: An NCDB Investigation. Ann Thorac Surg 2021;112:459-66. [PMID: 33096068 DOI: 10.1016/j.athoracsur.2020.08.034] [Reference Citation Analysis]
4 Kawamoto T, Nakamura N, Saito T, Tonari A, Wada H, Harada H, Kubota H, Nagakura H, Heianna J, Miyazawa K, Yamada K, Tago M, Fushiki M, Nozaki M, Uchida N, Araki N, Sekii S, Kosugi T, Takahashi T, Shikama N. Palliative brachytherapy and external beam radiotherapy for dysphagia from esophageal cancer: a nationwide survey in Japan. Jpn J Clin Oncol 2021;51:950-5. [PMID: 33624768 DOI: 10.1093/jjco/hyab015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Reddy VK, Jain V, Venigalla S, Nimgaokar V, Amurthur A, Lee DY, Sebro RA, Maki RG, Wilson RJ 2nd, Weber KL, Shabason JE. Definitive Local Therapy Is Associated with Improved Survival in Metastatic Soft Tissue Sarcomas. Cancers (Basel) 2021;13:932. [PMID: 33668098 DOI: 10.3390/cancers13050932] [Reference Citation Analysis]
6 Venigalla S, Guttmann DM, Horne ZD, Carmona R, Shabason JE, Beriwal S. Definitive local therapy is associated with improved overall survival in metastatic cervical cancer. Pract Radiat Oncol 2018;8:e377-85. [PMID: 30174248 DOI: 10.1016/j.prro.2018.05.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
7 Chen Y, Cheng X, Song H, Wu AJ, Ku GY, Lee P, Slingerland M, Koyanagi K, Ke S, Qiu H, Shi W, Gao Y, Chen J; written on behalf of AME Radiation Oncology Collaborative Group. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for esophageal squamous cell cancer patients presenting with oligometastases. J Thorac Dis 2019;11:1536-45. [PMID: 31179097 DOI: 10.21037/jtd.2019.03.10] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
8 Guo J, Zhang S, Li H, Hassan MOO, Lu T, Zhao J, Zhang L. Lung Metastases in Newly Diagnosed Esophageal Cancer: A Population-Based Study. Front Oncol 2021;11:603953. [PMID: 33718154 DOI: 10.3389/fonc.2021.603953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shi Z, Zhu X, Ke S, Qiu H, Cai G, Zhangcai Y, Chen Y. Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses. Radiother Oncol 2021;164:236-44. [PMID: 34627936 DOI: 10.1016/j.radonc.2021.09.033] [Reference Citation Analysis]
10 Deng J, Chu X, Ren Z, Wang B. Relationship between T stage and survival in distantly metastatic esophageal cancer: A STROBE-compliant study. Medicine (Baltimore) 2020;99:e20064. [PMID: 32384472 DOI: 10.1097/MD.0000000000020064] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ólafsdóttir HS, Klevebro F, Ndegwa N, Alexandersson von Döbeln G. Short-course compared to long-course palliative radiotherapy for oesophageal cancer: a single centre observational cohort study. Radiat Oncol 2021;16:153. [PMID: 34399793 DOI: 10.1186/s13014-021-01880-9] [Reference Citation Analysis]
12 Li Q, Deng M, Xi M, Zhu Y, Hu Y. Characteristics and Treatment of Brain Metastases from Esophageal Squamous Cell Carcinoma. J Cancer 2018;9:901-5. [PMID: 29581768 DOI: 10.7150/jca.21511] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Qiu B, Zhou Y, Lou M, Zhang K, Lu J, Tong J. The Effect of the Appropriate Timing of Radiotherapy on Survival Benefit in Patients with Metastatic Esophageal Cancer Who Have Undergone Resection of Primary Site: A SEER Database Analysis. J Oncol 2022;2022:6086953. [PMID: 35342414 DOI: 10.1155/2022/6086953] [Reference Citation Analysis]
14 Cheng W, Shi X, Lin M, Yao Q, Ma J, Li J. LncRNA MAGI2-AS3 Overexpression Sensitizes Esophageal Cancer Cells to Irradiation Through Down-Regulation of HOXB7 via EZH2. Front Cell Dev Biol 2020;8:552822. [PMID: 33330444 DOI: 10.3389/fcell.2020.552822] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Xu JY, Chen JN, Lei J, Hu M, Wu SG, Zhou J. Local treatment improves survival in patients with stage IVB cervical cancer. Gynecol Oncol 2022:S0090-8258(22)00254-2. [PMID: 35490033 DOI: 10.1016/j.ygyno.2022.04.013] [Reference Citation Analysis]
16 Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L. Sites of metastasis and overall survival in esophageal cancer: a population-based study. Cancer Manag Res. 2017;9:781-788. [PMID: 29255373 DOI: 10.2147/cmar.s150350] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
17 Zhang S, Liao W, Wu Q, Huang X, Pan Z, Chen W, Gu S, Huang Z, Wang Y, Tang X, Liang S, Zhang X, Chen Y, Chen S, Chen W, Jiang Y, Chen C, Qiu G. LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2. Cancer Cell Int 2020;20:569. [PMID: 33292221 DOI: 10.1186/s12935-020-01620-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Tang X, Zhou X, Li Y, Tian X, Wang Y, Huang M, Ren L, Zhou L, Ding Z, Zhu J, Xu Y, Peng F, Wang J, Lu Y, Gong Y. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study. Ann Surg Oncol 2019;26:321-8. [DOI: 10.1245/s10434-018-6929-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
19 Shah NK, Yegya-Raman N, Jones JA, Shabason JE. Radiation Therapy in Metastatic Soft Tissue Sarcoma: From Palliation to Ablation. Cancers (Basel) 2021;13:4775. [PMID: 34638260 DOI: 10.3390/cancers13194775] [Reference Citation Analysis]